Angiogenesis in transgenic models of multistep angiogenesis.
The histopathology and the epidemiology of human cancers, as well as studies of animal models of tumorigenesis, have led to a widely accepted notion that multiple genetic and epigenetic changes have to accumulate for progression to malignancy. Formation of new blood vessels (tumor angiogenesis) has been recognized, in addition to proliferative capabilities and ability to down-modulate cell death (apoptosis), as essential for the progressive growth and expansion of solid tumors. Mice overexpressing activated forms of oncogenes or carrying targeted mutations in tumor suppressor genes have proven extremely useful for linking the function of these genes with specific tumor features such as continuous proliferation, escape from apoptosis, invasion and neo-angiogenesis. The interbreeding of these mice allows for studying the extent of cooperativity between different genetic lesions in disease progression, leading to a greater understanding of multi-stage nature of tumorigenesis.
Radovanovic
Ivan
I
Institute of Neuropathology, University Hospital of Zürich, Zürich, Switzerland.
D'Angelo
Maria G
MG
Aguzzi
Adriano
A
D000818:Animals; D017209:Apoptosis; D001932:Brain Neoplasms / Q000473:pathology*; D002465:Cell Movement; D018450:Disease Progression; D015536:Down-Regulation; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D009369:Neoplasms / Q000098:blood supply* / Q000473:pathology; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000235:genetics / Q000473:pathology; D009389:Neovascularization, Pathologic